Independent equity research
Is Stride (LRN) a Buy, Hold or Sell?
Stride — our independent, AI-built valuation and rating, in brief.
BUY (accumulate)
12-mo fair value
$98.00
To fair value
+22%
By · report dated 2026-08-12 · fair value derived independently of the market price.
The thesis, in brief
At 4.7x EV/adjusted EBITDA and a reverse DCF implying only +0.3% perpetual FCF growth, Stride is priced for terminal decline; Career Learning (41% of revenue, +19% in FY26) should offset a shrinking General Education book, and the thesis fails if FY27 Q1 count-date enrolment falls year over year
How we value it
We value Stride using 10-yr DCF on owner FCF (FCF after SBC), WACC 11.6%, g 2.0%, peer EV/EBITDA cross-check. The 12-month fair value is set from that intrinsic estimate first, then compared to the market to read the upside or downside — never anchored to the current price.
What the full report covers
- Business & moat + industry cycle
- Earnings quality & normalized EPS
- Returns on capital (ROIC vs WACC)
- Balance-sheet safety
- Two independent valuations (DCF + multiples)
- Bear / base / bull fair values
- Earnings-call analysis
- Insider activity & positioning
- Technicals (RSI / ADX)
- A falsifiable thesis
Read the full Stride report
The complete model, the scenarios, and every number behind the call — plus other names across the coverage. One subscription, cancel anytime.